Six­teen-year-old dies af­ter re­ceiv­ing Sarep­ta’s Duchenne gene ther­a­py

A teenage boy who re­ceived Sarep­ta’s Duchenne mus­cu­lar dy­s­tro­phy gene ther­a­py Ele­v­idys died from liv­er fail­ure, the biotech said Tues­day morn­ing.

Sarep­ta told End­points News …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER